Become a Member
Dark Mode
Become a Member
Members Only
Latest News
Special Projects
Neon
FIT
Webqoof
My Report
Brand Studio
Indian Diaspora
Entertainment
Opinion
World
Videos
Podcasts
Sports
Law
More
Gender
Climate Change
FAQs
Explainers
Graphic Novels
Education
Quint Lab
Business
Good News
Members' Opinion
Photos
Dark Mode
Become a Member
Home
Elections
Jobs
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
×
×
clinical trials
Ocugen Files Application With FDA To Conduct Phase 3 Trials of Covaxin in US
Decoding Covaxin's Final Phase 3 Trial Data With Dr Shahid Jameel
ADVERTISEMENT
Covaxin COVID Vaccine 77.8% Effective; 10 Things to Know About the Phase 3 Data
Zydus Cadila Trial for 12-18 Concluded, 5 Cr Jabs by Dec: Centre
Is COVID-19 Vaccine Research Failing Pregnant Women?
Novavax Covid Vaccine Trial on Children to Begin in July: SII
Covaxin Phase II/III Trials for Children To Begin in 10-12 Days
Explained: Is the Data From Covaxin Trial’s Bhopal Site Tainted?
Indigenous COVID Vaccine Covaxin Has Drawn Global Attention: ICMR
DCGI Approves Phase II/III Trials of Covaxin in 2-18 Age Group
Zydus Cadila's COVID Vaccine Offers Immunity in Phase 1/2 Trials
India’s Indigenous mRNA COVID Vaccine Gets Nod For Human Trials
Ocugen Files Application With FDA To Conduct Phase 3 Trials of Covaxin in US
Decoding Covaxin's Final Phase 3 Trial Data With Dr Shahid Jameel
Covaxin COVID Vaccine 77.8% Effective; 10 Things to Know About the Phase 3 Data
Zydus Cadila Trial for 12-18 Concluded, 5 Cr Jabs by Dec: Centre
Is COVID-19 Vaccine Research Failing Pregnant Women?
Novavax Covid Vaccine Trial on Children to Begin in July: SII
ADVERTISEMENT
Covaxin Phase II/III Trials for Children To Begin in 10-12 Days
DCGI Approves Phase II/III Trials of Covaxin in 2-18 Age Group
Explained: Is the Data From Covaxin Trial’s Bhopal Site Tainted?
Indigenous COVID Vaccine Covaxin Has Drawn Global Attention: ICMR
Zydus Cadila's COVID Vaccine Offers Immunity in Phase 1/2 Trials
India’s Indigenous mRNA COVID Vaccine Gets Nod For Human Trials
Load More
